Offer - Urjas Oil for just ₹ 1 X
Vicard T 1 Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of High BP. Secondary and off-label uses of Vicard T 1 Tablet have also been mentioned below.
The right dosage of Vicard T 1 Tablet depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The side effects typically associated with Vicard T 1 Tablet include Nasal congestion, Sinus inflammation. Apart from the aforementioned side effects, Vicard T 1 Tablet can also lead to other problems, which have been listed below. These side effects of Vicard T 1 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Vicard T 1 Tablet is Severe for pregnant women and Severe for women who are breastfeeding. In addition, Vicard T 1 Tablet's effects on the liver, heart and kidney are discussed below in the Vicard T 1 Tablet related warnings section.
Individuals suffering from medical conditions like Low Blood Pressure (Hypotension) must refrain from the use of Vicard T 1 Tablet since this can cause severe adverse effects. Other contraindications of Vicard T 1 Tablet have been discussed in the sections ahead.
Additionally, Vicard T 1 Tablet may also adversely react with other medicines. See below for a complete list.
You should also be aware that Vicard T 1 Tablet is not safe while driving, and is not addiction.
Vicard T 1 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Vicard T 1 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Vicard T. If you are pregnant, do not take Vicard T without a doctor's advice.
Is the use of Vicard T 1 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Vicard T. It should only be taken after medical advice.
What is the effect of Vicard T 1 Tablet on the Kidneys?
Vicard T is completely safe for kidneys.
What is the effect of Vicard T 1 Tablet on the Liver?
Very few cases of side effects of Vicard T on the liver have been reported.
What is the effect of Vicard T 1 Tablet on the Heart?
Vicard T is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Vicard T 1 Tablet unless your doctor advises you to do so -
Is this Vicard T 1 Tablet habit forming or addictive?
Vicard T 1 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Vicard T 1 Tablet as you may feel sleepy.
Is it safe?
Vicard T 1 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Vicard T 1 Tablet for mental disorders.
Interaction between Food and Vicard T 1 Tablet
Taking Vicard T 1 Tablet with food does not cause any problems.
Interaction between Alcohol and Vicard T 1 Tablet
Consumption of alcohol and Vicard T 1 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hytrin (terazosin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 142
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1180-1182